Duchenne kas distrofisi (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Duchenne kas distrofisi" in Turkish language version.

refsWebsite

Global rank Turkish rank

14nih.gov

4^th place

11^th place

13web.archive.org

1^st place

11doi.org

2^nd place

4^th place

2archive.org

6^th place

2forschungsportal.ch

low place

2fda.gov

447^th place

858^th place

1books.google.com

3^rd place

5^th place

1mayoclinic.org

1,610^th place

1,902^nd place

1utah.edu

2,446^th place

1,491^st place

1psu.edu

207^th place

424^th place

1ucl.ac.uk

1,306^th place

1,131^st place

1medscape.com

719^th place

582^nd place

1unina2.it

low place

1uildm.org

low place

1medterms.com

8,430^th place

6,781^st place

1whonamedit.com

2,888^th place

3,674^th place

archive.org

Sutherland, DH; Olshen, R; Cooper, L; Wyatt, M; Leach, J; Mubarak, S; Schultz, P (February 1981). "The pathomechanics of gait in Duchenne muscular dystrophy". Developmental Medicine and Child Neurology. 23 (1): 3-22. doi:10.1111/j.1469-8749.1981.tb08442.x. PMID 7202868.
Muntoni F (August 2001). "Is a muscle biopsy in Duchenne dystrophy really necessary?". Neurology. 57 (4): 574-5. doi:10.1212/wnl.57.4.574. PMID 11524463.

books.google.com

Lisak, Robert P.; Truong, Daniel D.; Carroll, William; Bhidayasiri, Roongroj (2011). International Neurology. Wiley. s. 222. ISBN 9781444317015.

doi.org

Nozoe KT, Akamine RT, Mazzotti DR, Polesel DN, Grossklauss LF, Tufik S (2016). "Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports". Sleep Sci. 9 (3): 129-133. doi:10.1016/j.slsci.2016.07.004. PMC 5241604 $2. PMID 28123647.
Angelini, C; Tasca, E (December 2012). "Fatigue in muscular dystrophies". Neuromuscular Disorders. 22 Suppl 3: S214-20. doi:10.1016/j.nmd.2012.10.010. PMC 3526799 $2. PMID 23182642.
Sutherland, DH; Olshen, R; Cooper, L; Wyatt, M; Leach, J; Mubarak, S; Schultz, P (February 1981). "The pathomechanics of gait in Duchenne muscular dystrophy". Developmental Medicine and Child Neurology. 23 (1): 3-22. doi:10.1111/j.1469-8749.1981.tb08442.x. PMID 7202868.
Baptista, CR; Costa, AA; Pizzato, TM; Souza, FB; Mattiello-Sverzut, AC (2014). "Postural alignment in children with Duchenne muscular dystrophy and its relationship with balance". Brazilian Journal of Physical Therapy. 18 (2): 119-26. doi:10.1590/s1413-35552012005000152. PMC 4183248 $2. PMID 24838810.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (January 2010). "Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management". The Lancet. Neurology. 9 (1): 77-93. CiteSeerX 10.1.1.176.4466 $2. doi:10.1016/s1474-4422(09)70271-6. PMID 19945913.
Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E (September 1993). "Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients". Journal of Medical Genetics. 30 (9): 737-44. doi:10.1136/jmg.30.9.737. PMC 1016530 $2. PMID 8411068.
Muntoni F (August 2001). "Is a muscle biopsy in Duchenne dystrophy really necessary?". Neurology. 57 (4): 574-5. doi:10.1212/wnl.57.4.574. PMID 11524463.
Dany A, Barbe C, Rapin A, Réveillère C, Hardouin JB, Morrone I, Wolak-Thierry A, Dramé M, Calmus A, Sacconi S, Bassez G, Tiffreau V, Richard I, Gallais B, Prigent H, Taiar R, Jolly D, Novella JL, Boyer FC (November 2015). "Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease". Quality of Life Research. 24 (11): 2615-23. doi:10.1007/s11136-015-1013-8. PMID 26141500.
Falzarano MS, Scotton C, Passarelli C, Ferlini A (October 2015). "Duchenne Muscular Dystrophy: From Diagnosis to Therapy". Molecules. 20 (10): 18168-84. doi:10.3390/molecules201018168. PMC 6332113 $2. PMID 26457695.
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (May 2016). "Corticosteroids for the treatment of Duchenne muscular dystrophy". The Cochrane Database of Systematic Reviews. 5 (5): CD003725. doi:10.1002/14651858.CD003725.pub4. PMID 27149418. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Temmuz 2021.
"Railroading at the FDA". Nature Biotechnology. 34 (11): 1078. 8 Kasım 2016. doi:10.1038/nbt.3733 . PMID 27824847.

fda.gov

"Duchenne Muscular Dystrophy Statement". Drug Safety and Availability. US FDA. 31 Ekim 2014. 2 Kasım 2014 tarihinde kaynağından arşivlendi.
"FDAetep". 19 Eylül 2016. 20 Eylül 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Temmuz 2019.

forschungsportal.ch

"Duchenne Muscular Dystrophy: Pathophysiological Implications of Mitochondrial Calcium Signaling and ROS Production". 2 Mayıs 2012. 2 Mayıs 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Haziran 2014.
"Duchenne Muscular Dystrophy: Pathophysiological Implications of Mitochondrial Calcium Signaling and ROS Production". 2 Mayıs 2012. 2 Mayıs 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Haziran 2014.

mayoclinic.org

"Muscular dystrophy - Symptoms and causes". 6 Şubat 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Şubat 2015.

medscape.com

"CHMP Advises Against Approval for Eteplirsen in DMD". Medscape. 9 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Temmuz 2019.

medterms.com

"Duchenne muscular dystrophy". Medterms.com. 27 Nisan 2011. 6 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Şubat 2013.

nih.gov

ncbi.nlm.nih.gov

Nozoe KT, Akamine RT, Mazzotti DR, Polesel DN, Grossklauss LF, Tufik S (2016). "Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports". Sleep Sci. 9 (3): 129-133. doi:10.1016/j.slsci.2016.07.004. PMC 5241604 $2. PMID 28123647.
Angelini, C; Tasca, E (December 2012). "Fatigue in muscular dystrophies". Neuromuscular Disorders. 22 Suppl 3: S214-20. doi:10.1016/j.nmd.2012.10.010. PMC 3526799 $2. PMID 23182642.
Sutherland, DH; Olshen, R; Cooper, L; Wyatt, M; Leach, J; Mubarak, S; Schultz, P (February 1981). "The pathomechanics of gait in Duchenne muscular dystrophy". Developmental Medicine and Child Neurology. 23 (1): 3-22. doi:10.1111/j.1469-8749.1981.tb08442.x. PMID 7202868.
Baptista, CR; Costa, AA; Pizzato, TM; Souza, FB; Mattiello-Sverzut, AC (2014). "Postural alignment in children with Duchenne muscular dystrophy and its relationship with balance". Brazilian Journal of Physical Therapy. 18 (2): 119-26. doi:10.1590/s1413-35552012005000152. PMC 4183248 $2. PMID 24838810.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (January 2010). "Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management". The Lancet. Neurology. 9 (1): 77-93. CiteSeerX 10.1.1.176.4466 $2. doi:10.1016/s1474-4422(09)70271-6. PMID 19945913.
Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E (September 1993). "Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients". Journal of Medical Genetics. 30 (9): 737-44. doi:10.1136/jmg.30.9.737. PMC 1016530 $2. PMID 8411068.
Muntoni F (August 2001). "Is a muscle biopsy in Duchenne dystrophy really necessary?". Neurology. 57 (4): 574-5. doi:10.1212/wnl.57.4.574. PMID 11524463.
Dany A, Barbe C, Rapin A, Réveillère C, Hardouin JB, Morrone I, Wolak-Thierry A, Dramé M, Calmus A, Sacconi S, Bassez G, Tiffreau V, Richard I, Gallais B, Prigent H, Taiar R, Jolly D, Novella JL, Boyer FC (November 2015). "Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease". Quality of Life Research. 24 (11): 2615-23. doi:10.1007/s11136-015-1013-8. PMID 26141500.
Falzarano MS, Scotton C, Passarelli C, Ferlini A (October 2015). "Duchenne Muscular Dystrophy: From Diagnosis to Therapy". Molecules. 20 (10): 18168-84. doi:10.3390/molecules201018168. PMC 6332113 $2. PMID 26457695.
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (May 2016). "Corticosteroids for the treatment of Duchenne muscular dystrophy". The Cochrane Database of Systematic Reviews. 5 (5): CD003725. doi:10.1002/14651858.CD003725.pub4. PMID 27149418. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Temmuz 2021.
"Railroading at the FDA". Nature Biotechnology. 34 (11): 1078. 8 Kasım 2016. doi:10.1038/nbt.3733 . PMID 27824847.
Nigro G (December 2010). "One-hundred-seventy-five years of Neapolitan contributions to the fight against the muscular diseases". Acta Myologica. 29 (3): 369-91. PMC 3146338 $2. PMID 21574522.

ninds.nih.gov

"Muscular Dystrophy: Hope Through Research". National Institute of Neurological Disorders and Stroke. 4 Ocak 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ağustos 2020.

rarediseases.info.nih.gov

"Duchenne muscular dystrophy | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. 23 Kasım 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2021.

psu.edu

citeseerx.ist.psu.edu

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (January 2010). "Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management". The Lancet. Neurology. 9 (1): 77-93. CiteSeerX 10.1.1.176.4466 $2. doi:10.1016/s1474-4422(09)70271-6. PMID 19945913.

ucl.ac.uk

discovery.ucl.ac.uk

Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (May 2016). "Corticosteroids for the treatment of Duchenne muscular dystrophy". The Cochrane Database of Systematic Reviews. 5 (5): CD003725. doi:10.1002/14651858.CD003725.pub4. PMID 27149418. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Temmuz 2021.

uildm.org

De Rosa, Giulio (October 2005). "Da Conte a Duchenne" [By Conte in Duchenne]. DM (İtalyanca). Unione Italiana Lotta alla Distrofia Muscolare. 4 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ağustos 2015.

unina2.it

cardiomiologia.unina2.it

Politano, Luisa. "Cardiomiologia e Genetica Medica" [Cardiomyology and Medical Genetics] (İtalyanca). Seconda Università degli Studi di Napoli. 4 Temmuz 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ağustos 2015.

utah.edu

genome.utah.edu

"University of Utah Muscular Dystrophy". Genome.utah.edu. 28 Kasım 2009. 14 Eylül 2003 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Şubat 2013.

web.archive.org

"Muscular Dystrophy: Hope Through Research". National Institute of Neurological Disorders and Stroke. 4 Ocak 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ağustos 2020.
"Duchenne muscular dystrophy | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. 23 Kasım 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ocak 2021.
"Muscular dystrophy - Symptoms and causes". 6 Şubat 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 6 Şubat 2015.
"Duchenne Muscular Dystrophy: Pathophysiological Implications of Mitochondrial Calcium Signaling and ROS Production". 2 Mayıs 2012. 2 Mayıs 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Haziran 2014.
"Duchenne Muscular Dystrophy: Pathophysiological Implications of Mitochondrial Calcium Signaling and ROS Production". 2 Mayıs 2012. 2 Mayıs 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Haziran 2014.
"University of Utah Muscular Dystrophy". Genome.utah.edu. 28 Kasım 2009. 14 Eylül 2003 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Şubat 2013.
"Duchenne Muscular Dystrophy Statement". Drug Safety and Availability. US FDA. 31 Ekim 2014. 2 Kasım 2014 tarihinde kaynağından arşivlendi.
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY (May 2016). "Corticosteroids for the treatment of Duchenne muscular dystrophy". The Cochrane Database of Systematic Reviews. 5 (5): CD003725. doi:10.1002/14651858.CD003725.pub4. PMID 27149418. 29 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Temmuz 2021.
"FDAetep". 19 Eylül 2016. 20 Eylül 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Temmuz 2019.
"CHMP Advises Against Approval for Eteplirsen in DMD". Medscape. 9 Temmuz 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Temmuz 2019.
Politano, Luisa. "Cardiomiologia e Genetica Medica" [Cardiomyology and Medical Genetics] (İtalyanca). Seconda Università degli Studi di Napoli. 4 Temmuz 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ağustos 2015.
De Rosa, Giulio (October 2005). "Da Conte a Duchenne" [By Conte in Duchenne]. DM (İtalyanca). Unione Italiana Lotta alla Distrofia Muscolare. 4 Mart 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ağustos 2015.
"Duchenne muscular dystrophy". Medterms.com. 27 Nisan 2011. 6 Ağustos 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Şubat 2013.

whonamedit.com

Duchenne de Boulogne ; ("İsmini Kimden Aldı" websitesi) Whonamedit?